Discover
XBIT
XBiotech Inc.
2.24
10 x 2.24
3 x 2.32
bid
ask
-
0.01
0.44%
04:00 PM
| Ytd | -6.28% | |
| 1y | -24.07% |
2.20
day range
2.26
2.09
52 week range
3.61
| Open | 2.20 | Prev Close | 2.25 | Low | 2.20 | High | 2.26 | Mkt Cap | 68.29M |
| Vol | 106.90K | Avg Vol | 31.84K | EPS | -1.32 | P/E | -1.70 | Forward P/E | 34.62 |
| Beta | 0.86 | Short Ratio | 15.03 | Inst. Own | 16.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 07-15 | Earning | 08-15 | 50-d Avg | 2.37 | 200-d Avg | 2.42 | 1yr Est | 13.00 |
| Income Statement | |||
| Operating Expenses | 6.27M | ||
| Research and Development Expense | 5.21M | ||
| Selling, General and Administrative Expense | 1.07M | ||
| Operating Income | -6.27M | ||
| Income Tax Expense | 49.00K | ||
| Net Income | -5.50M | ||
| Net Income Common Stock | -5.50M | ||
| Net Income Common Stock (USD) | -5.50M | ||
| Consolidated Income | -5.50M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -5.46M | ||
| Earning Before Interest & Taxes (USD) | -5.46M | ||
| Weighted Average Shares | 30.49M | ||
| Weighted Average Shares Diluted | 30.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 115.46M | ||
| Cash and Equivalents (USD) | 115.46M | ||
| Current Assets | 117.05M | ||
| Property, Plant & Equipment Net | 22.79M | ||
| Total Assets | 139.84M | ||
| Current Liabilities | 3.00M | ||
| Total Liabilities | 4.82M | ||
| Accumulated Retained Earnings (Deficit) | -141.88M | ||
| Shareholders Equity | 135.02M | ||
| Shareholders Equity (USD) | 135.02M | ||
| Assets Non-Current | 22.79M | ||
| Liabilities Non-Current | 1.82M | ||
| Trade and Non-Trade Payables | 857.00K | ||
| Tax Liabilities | 1.93M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 332.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.09M | ||
| Capital Expenditure | 9.00K | ||
| Net Cash Flow from Investing | 9.00K | ||
| Net Cash Flow from Operations | -8.97M | ||
| Effect of Exchange Rate Changes on Cash | -1.13M | ||
| Share Based Compensation | 172.00K | ||